Synergy Pharma: 3Q Earnings Snapshot

Associated Press |

NEW YORK (AP) _ Synergy Pharmaceuticals Inc. (SGYP) on Thursday reported a loss of $34.5 million in its third quarter.

On a per-share basis, the New York-based company said it had a loss of 14 cents.

The biopharmaceutical company posted revenue of $11.1 million in the period.

In the final minutes of trading on Thursday, the company's shares hit 45 cents. A year ago, they were trading at $2.93.

This story was generated by Automated Insights ( using data from Zacks Investment Research. Access a Zacks stock report on SGYP at

DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure, please go to:


Emerging Growth

CMX Gold & Silver Corp.

CMX Gold & Silver Corp is an exploration stage company. The Company is engaged in the acquisition, exploration and development of silver and copper/gold properties in the USA.